Triveni Incredible Cure Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 15 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.33 M
- Revenue Growth -100.00%
- Profit Growth -106.67%
- Ebitda 52.67%
- Net Worth -0.28%
- Total Assets 56.01%
About Triveni Incredible Cure
Triveni Incredible Cure Private Limited (TICPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 January 2019 (Six years 15 days old ). Its registered office is in Karnal, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.33 M.
Santosh Yadav and Satya Yadav serve as directors at the Company.
Company Details
-
Location
Karnal, Haryana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85100HR2019PTC078159
-
Company No.
078159
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jan 2019
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Triveni Incredible Cure?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Yadav
|
Director | 29-Jan-2019 | Current |
|
Satya Yadav
|
Director | 29-Jan-2019 | Current |
Financial Performance of Triveni Incredible Cure.
Triveni Incredible Cure Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 106.67% decrease in profit. The company's net worth dipped by a decrease of 0.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Triveni Incredible Cure?
Unlock access to Triveni Incredible Cure's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.33 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Aug 2019 | Others | ₹0.33 M | Open |
How Many Employees Work at Triveni Incredible Cure?
Unlock and access historical data on people associated with Triveni Incredible Cure, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Triveni Incredible Cure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triveni Incredible Cure's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.